Found: 62
Select item for more details and to access through your institution.
Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates.
- Published in:
- Journal of Clinical Medicine, 2017, v. 6, n. 4, p. 39, doi. 10.3390/jcm6040039
- By:
- Publication type:
- Article
Males are cheaper, or the extreme consequence of size/age-dependent sex allocation: sexist gender diphasy in Fritillaria montana (Liliaceae).
- Published in:
- Botanical Journal of the Linnean Society, 2012, v. 168, n. 3, p. 323, doi. 10.1111/j.1095-8339.2011.01204.x
- By:
- Publication type:
- Article
A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 5, p. 756, doi. 10.1111/ejh.14167
- By:
- Publication type:
- Article
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 544, doi. 10.1111/ejh.14040
- By:
- Publication type:
- Article
Recombinant factor VIII Fc for the treatment of haemophilia A.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 745, doi. 10.1111/ejh.13610
- By:
- Publication type:
- Article
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.
- Published in:
- European Journal of Haematology, 2017, v. 98, p. 1, doi. 10.1111/ejh.12828
- By:
- Publication type:
- Article
Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies.
- Published in:
- Haemophilia, 2024, v. 30, p. 39, doi. 10.1111/hae.14976
- By:
- Publication type:
- Article
Prevalence of COVID‐19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 913, doi. 10.1111/hae.14761
- By:
- Publication type:
- Article
Synovitis and joint health in patients with haemophilia: Statements from a European e‐Delphi consensus study.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 619, doi. 10.1111/hae.14734
- By:
- Publication type:
- Article
Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 435, doi. 10.1111/hae.14709
- By:
- Publication type:
- Article
Emicizumab dose up‐titration in case of suboptimal bleeding control in people with haemophilia A.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 90, doi. 10.1111/hae.14679
- By:
- Publication type:
- Article
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 33, doi. 10.1111/hae.14676
- By:
- Publication type:
- Article
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 21, doi. 10.1111/hae.14674
- By:
- Publication type:
- Article
Befovacimab, an anti‐tissue factor pathway inhibitor antibody: Early termination of the multiple‐dose, dose‐escalating Phase 2 study due to thrombosis.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 702, doi. 10.1111/hae.14595
- By:
- Publication type:
- Article
Managing invasive procedures in haemophilia patients with limited resources, extended half‐life concentrates or non‐replacement therapies in 2022.
- Published in:
- Haemophilia, 2022, v. 28, p. 93, doi. 10.1111/hae.14551
- By:
- Publication type:
- Article
Managing invasive procedures in haemophilia patients with limited resources, extended half‐life concentrates or non‐replacement therapies in 2022.
- Published in:
- Haemophilia, 2022, v. 28, p. 93, doi. 10.1111/hae.14551
- By:
- Publication type:
- Article
Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. 55, doi. 10.1111/hae.14431
- By:
- Publication type:
- Article
Prophylaxis in children with haemophilia in an evolving treatment landscape.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 889, doi. 10.1111/hae.14412
- By:
- Publication type:
- Article
Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e347, doi. 10.1111/hae.14297
- By:
- Publication type:
- Article
PROTECT VIII kids extension study: Long‐term safety and efficacy of BAY 94‐9027 (damoctocog alfa pegol) in children with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 434, doi. 10.1111/hae.14294
- By:
- Publication type:
- Article
Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1009, doi. 10.1111/hae.14183
- By:
- Publication type:
- Article
Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 937, doi. 10.1111/hae.14172
- By:
- Publication type:
- Article
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 637, doi. 10.1111/hae.14018
- By:
- Publication type:
- Article
Target joint resolution in patients with haemophilia A receiving long‐term prophylaxis with BAY 94‐9027.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. e201, doi. 10.1111/hae.13982
- By:
- Publication type:
- Article
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 521, doi. 10.1111/hae.13746
- By:
- Publication type:
- Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 382, doi. 10.1111/hae.13731
- By:
- Publication type:
- Article
Usefulness of bone microarchitectural and geometric DXA‐derived parameters in haemophilic patients.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 980, doi. 10.1111/hae.13611
- By:
- Publication type:
- Article
Once‐weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9‐GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm™ trials.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 911, doi. 10.1111/hae.13608
- By:
- Publication type:
- Article
Crimean-Congo Hemorrhagic Fever Virus Genome in Tick from Migratory Bird, Italy.
- Published in:
- 2019
- By:
- Publication type:
- letter
High rate of sustained virological response with direct‐acting antivirals in haemophiliacs with HCV infection: A multicenter study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1062, doi. 10.1111/liv.14337
- By:
- Publication type:
- Article
Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials.
- Published in:
- Journal of Blood Medicine, 2023, v. 14, p. 427, doi. 10.2147/JBM.S389094
- By:
- Publication type:
- Article
Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 935, doi. 10.2147/JBM.S321288
- By:
- Publication type:
- Article
GlycoPEGylated recombinant factor IX for hemophilia B in context.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 2933, doi. 10.2147/DDDT.S121743
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 2, p. 649, doi. 10.1007/s12325-023-02745-1
- By:
- Publication type:
- Article
Morphology, germination, and storage behaviour in seeds of Tuscan populations of Fritillaria montana (Liliaceae), a rare perennial geophyte in Italy.
- Published in:
- Turkish Journal of Botany, 2012, v. 36, n. 2, p. 161, doi. 10.3906/bot-1102-9
- By:
- Publication type:
- Article
Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 5, p. 689, doi. 10.1111/j.1365-2141.2008.07087.x
- By:
- Publication type:
- Article
Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 3, p. 422, doi. 10.1111/j.1365-2141.2005.05605.x
- By:
- Publication type:
- Article
Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 365, doi. 10.2147/DDDT.S47312
- By:
- Publication type:
- Article
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands.
- Published in:
- European Journal of Haematology, 2016, v. 97, p. 3, doi. 10.1111/ejh.12760
- By:
- Publication type:
- Article
Platelets: much more than bricks in a breached wall.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 2, p. 209, doi. 10.1111/bjh.14653
- By:
- Publication type:
- Article
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Direct and Indirect Role of Migratory Birds in Spreading CCHFV and WNV: A Multidisciplinary Study on Three Stop-Over Islands in Italy.
- Published in:
- Pathogens, 2022, v. 11, n. 9, p. N.PAG, doi. 10.3390/pathogens11091056
- By:
- Publication type:
- Article
Tick Species Diversity and Molecular Identification of Spotted Fever Group Rickettsiae Collected from Migratory Birds Arriving from Africa.
- Published in:
- Microorganisms, 2023, v. 11, n. 8, p. 2036, doi. 10.3390/microorganisms11082036
- By:
- Publication type:
- Article
Summary report of the First International Conference on inhibitors in haemophilia A.
- Published in:
- Blood Transfusion (17232007), 2017, v. 15, n. 6, p. 568, doi. 10.2450/2016.0252-16
- By:
- Publication type:
- Article
Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment.
- Published in:
- Transfusion Medicine & Hemotherapy, 2013, v. 40, n. 5, p. 352, doi. 10.1159/000354843
- By:
- Publication type:
- Article
Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines.
- Published in:
- Human Mutation, 2020, v. 41, n. 12, p. 2058, doi. 10.1002/humu.24117
- By:
- Publication type:
- Article
Physical Activity, Bleedings and Quality of Life in Subjects with Haemophilia A without Inhibitors—A Multicenter, Observational Italian Study with a Wearable Device.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3036, doi. 10.3390/jcm13113036
- By:
- Publication type:
- Article
Better Communication for Better Management of Persons with Hemophilia: Results from a Patients'-Clinicians' Project to Address the New Therapeutic Landscape.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 568, doi. 10.3390/jcm13020568
- By:
- Publication type:
- Article
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2080, doi. 10.3390/jcm12052080
- By:
- Publication type:
- Article